Xiaodong Teng
Overview
Explore the profile of Xiaodong Teng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
754
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
S100A2 promotes clear cell renal cell carcinoma tumor metastasis through regulating GLUT2 expression
Deng M, Liao S, Deng J, Li C, Liu L, Han Q, et al.
Cell Death Dis
. 2025 Feb;
16(1):135.
PMID: 40011447
Clear cell renal cell carcinoma (ccRCC) is the predominant subtype of renal cancer and is highly malignant. Despite advances in diagnostics and treatment, the prognosis for ccRCC remains poor. The...
2.
Chen Z, Cao H, Zhang J, Zhong W, Teng X
BMC Cancer
. 2024 Nov;
24(1):1407.
PMID: 39548392
Background: Colorectal cancer (CRC) is a leading cause of cancer-related mortality, highlighting the necessity for multifaceted treatment strategies, including preoperative treatment (PT), which can enhance surgical outcomes and provide prognostic...
3.
Zhang J, Chen Z, Deng Y, Teng X, Ling X, He C, et al.
Sleep Breath
. 2024 Aug;
28(5):2135-2141.
PMID: 39115598
Background: Sympathetic nerve activation followed by obstructive sleep apnea (OSA) accounts for blood pressure elevation. The effectiveness of renal denervation (RDN) in controlling blood pressure in patients with OSA remains...
4.
Li L, Li W, Wu C, Xi Y, Guo L, Ji Y, et al.
Cancer Commun (Lond)
. 2024 Jul;
44(9):992-1004.
PMID: 39016057
Background: Anaplastic lymphoma kinase (ALK) test in advanced non-small cell lung cancer (NSCLC) can help physicians provide target therapies for patients harboring ALK gene rearrangement. This study aimed to investigate...
5.
Zhao M, Yin X, Yang X, Gan H, Chen N, Duan G, et al.
Mod Pathol
. 2024 Jun;
37(8):100536.
PMID: 38852815
ALK-rearranged renal cell carcinoma (ALK-RCC) is rare, molecularly defined RCC subtype in the recently published fifth edition of World Health Organization classification of tumors. In this study, we described 9...
6.
Zhao M, Song J, Yin X, Xu J, Teng X, Wang J
J Clin Pathol
. 2024 Jun;
PMID: 38839088
Aims: Mesenchymal neoplasms characterised by fusions mainly include inflammatory myofibroblastic tumour (IMT) and epithelioid fibrous histiocytoma (EFH). Most recently, -rearranged mesenchymal tumours that are not IMT or EFH have been...
7.
Zhang H, Wu W, Wu S, Teng X
Ann Diagn Pathol
. 2024 May;
72:152325.
PMID: 38733673
Primary mucinous tumors of the renal pelvis are extremely rare and pose challenges in terms of diagnosis and treatment. This study reviewed the clinical and pathological characteristics of mucinous tumors...
8.
Sun X, Teng X, Liu C, Tian W, Cheng J, Hao S, et al.
Adv Sci (Weinh)
. 2024 Apr;
11(26):e2308892.
PMID: 38682485
Heterogeneous organ-specific responses to immunotherapy exist in lung cancer. Dissecting tumor microenvironment (TME) can provide new insights into the mechanisms of divergent responses, the process of which remains poor, partly...
9.
Zhao M, Gan H, Zhong S, Xia Q, Bai Y, Xu J, et al.
Mod Pathol
. 2024 Mar;
37(5):100468.
PMID: 38460673
Soft tissue neoplasms, harboring fusions between EWSR1 and FUS with genes encoding CREB transcription factors family (ATF1, CREB1, and CREM), are an emerging heterogeneous group of mesenchymal tumors that differ...
10.
Yu F, Huang D, Kuang Y, Dong J, Han Q, Zhou J, et al.
Clin Endocrinol (Oxf)
. 2024 Jan;
100(3):284-293.
PMID: 38172081
Objective: Insulin receptor substract 1 (IRS1) protein is an important signal transduction adapter for extracellular signal transduction from insulin-like growth factor-1 receptor and its family members to IRS1 downstream proteins....